Hovione Expands Global Spray Drying Capacity with Significant Investment in the USA and Ireland
Hovione has completed significant expansions at its facilities in New Jersey, USA, and Cork, Ireland.
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione has completed significant expansions at its facilities in New Jersey, USA, and Cork, Ireland.
Hovione has once again solidified its position as a top employer.
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
Exclusive licensing and R&D collaboration accelerate the development of a novel gene vector platform for precision gene therapy in Hepatocellular Carcinoma - the third leading cause of cancer-related deaths worldwide
Presented by the Hénokiens Association and the Château du Clos Lucé
Collaboration unlocks multi-purpose capabilities to accelerate small molecule production
Investment More Than Doubles Capacity for Spray Drying, a Critical Solubility Enhancement Technology That Could Benefit the Development of 70% of Drugs*
The new ConsiGma® CDC Flex delivers unprecedented flexibility, simplicity, and cost-efficiency in continuous direct compression.